Close

CloudCath raises funds towards peritoneal dialysis monitoring system

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

WHO Supplies Medical Equipment for Post-Marburg...

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK...

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences...

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized...

The Human Medicines Regulations 2025, which came into force...

Digital health medical device company CloudCath has completed a $12m Series A funding round to commercialise a system that enables remote and live monitoring for patients undergoing at-home peritoneal dialysis.

It also plans to use the funds to support the development of additional applications utilising the company’s proprietary technology. Capital Integral led the funding round, with participation from FundRx, The Capital Partnership, Coconut Tree Investments, Stanford University’s StartX Fund and additional strategic and individual investors.

Seamlessly integrating into the patient’s drain line, CloudCath’s device helps to monitor the spent dialysate fluid on every dialysis cycle by measuring and quantifying the fluid properties remotely from the patients’ home.

CloudCath’s monitoring platform helps healthcare providers to log in and access real-time data from patients throughout treatment, to assist in decision management. CloudCath co-founder and CEO Aly ElBadr said: “End-stage renal disease, one of the costliest chronic diseases in the US, is devastating to patients.

“The CloudCath technology enables patients and caregivers to easily monitor fluid parameters for early signs of complications, including infection, in real-time, allowing dialysis providers to intervene much earlier than the existing standard of care.

Latest stories

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back